Rss Feed

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, and in partnership with the University of Exeter and the London School of Hygiene & Tropical Medicine, has found that women with a history of severe mental illness face a lower risk of relapse after giving birth in regions where they have access to a community perinatal mental health team (CPMHT).

Researchers developed the Splicing Neo Antigen Finder (SNAF) workflow, integrating deep learning to identify shared immunogenic neoantigens in cancers, offering new targets for cancer immunotherapy, particularly in melanoma and ovarian cancer.

While recent therapies have the potential to stall or delay the progression of multiple sclerosis, a new study shows that young Black and Hispanic women fare worse than young white women.

Study reveals that prolonged sitting at work increases the risk of all-cause and cardiovascular mortality, which can be mitigated by alternating sitting with non-sitting activities and engaging in 15-30 minutes of daily leisure-time physical activity.

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 1, entitled, "Systematic analysis of the prognostic value and immunological function of LTBR in human cancer."

The ability to walk one kilometer comfortably can help predict fracture risk, according to researchers at the Garvan Institute of Medical Research.

Study finds that clinically derived blood pressure variability (BPV), rather than heart rate variability (HRV), is more strongly associated with the risk of Alzheimer’s Disease and Related Dementias (ADRD).

Study found no direct link between total dietary vitamin A intake and non-alcoholic fatty liver disease (NAFLD) risk, but observed an inverse correlation between provitamin A carotenoid consumption and NAFLD risk.

Study reveals that recent weight loss in individuals aged 40 or older is significantly associated with an increased risk of cancer diagnosis within the following year, particularly upper gastrointestinal cancers.

Study evaluates the impact of gluten-free diets on women's health, revealing benefits for specific gluten-related disorders but cautioning against unnecessary dietary restrictions.

A new study at the University of Missouri's Thompson Center for Autism and Neurodevelopment found that propranolol, a medication that treats high blood pressure, can also help lower anxiety for kids and young adults with autism spectrum disorder (ASD).

Ozempic and other GLP1 agonists are associated with a reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease, according to a nationwide study from Karolinska Institutet in Sweden published in the journal Gut.

A research team led by Georg Stary (Medical University of Vienna and CeMM) has identified a new approach to treating the inflammatory disease sarcoidosis.

A combination therapy with multiple drugs is more effective than just one active compound. To begin with, at least.

Previous research has established that childhood experience with abuse, neglect, and substance use in the home can worsen a person's heart health throughout their life.

Over the last 20 years, researchers in biology and medicine have created Boolean network models to simulate complex systems and find solutions, including new treatments for colorectal cancer.

A novel rabbit infection model to investigate meropenem's resistance development.

A meta-analysis of 908,697 samples to investigate the genetic, sex-dependent basis of kidney traits.

Scientists at the Centro Nacional de Investigaciones Cardiovasculares in Madrid have found that one of the most potent genetic risk factors for Alzheimer disease, apolipoprotein E4 (APOE4), is also associated with an increased risk of developing subclinical atherosclerosis in middle age.

An international research team led by Krembil Brain Institute Neurologist and Senior Scientist, Dr. Anthony Lang, has proposed a new model for classifying Parkinson's disease (PD).